Warsaw-based Zimmer Biomet Holdings Inc. (NYSE: ZBH) has acquired an award-winning telerehabilitation technology. The company says the acquisition of RespondWell, which provides clinician-supervised post-surgical physical therapy in a patient’s home, strengthens its “Signature Solutions” offering.
Financial details of the acquisition were not released, however Zimmer Biomet says it has plans for a broad commercial release of the technology in 2017. The company says it is currently launching research partnerships at selected academic research institutions throughout the country.
"The new value-based reimbursement environment compels hospitals and providers to assume responsibility for patient outcomes well after discharge and through the critical rehabilitation period," said David Nolan with Zimmer Biomet. "Integrating an innovative and comprehensive telerehabilitation program addresses the emerging need for healthcare providers to oversee and optimize post-surgical recovery outcomes in order to maximize value across the entire episode of care."
Ted Spooner, co-founder and chief executive officer of RespondWell, says telerehabilitation "represents the future of optimal and efficient post-surgical patient care."